Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nordøy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Testicular cancer treated in a minor general oncology departmentJ Norum, T Nordøy, E Wist
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 30, 1995
[Testicular cancer treated at the regional hospital in Tromsø 1985-1993]J Norum, E Wist, T Nordøy, et al.
Anticancer Research|July 1, 1995
Subclassification of Hodgkin's disease, nodular sclerosis type. Prognostic value?J Norum, E Wist, T Nordøy, et al.
Bone Marrow Transplantation|October 12, 1999
Persistent changes in the immune system 4-10 years after ABMTT Nordøy, A Kolstad, P Endresen, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2001
Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigensT Nordøy, A Kolstad, M K Tuck, et al.
Journal of Pain and Symptom Management|July 26, 2000
High level of fatigue in lymphoma patients treated with high dose therapyH Knobel, J H Loge, T Nordøy, et al.
Bone Marrow Transplantation|November 13, 2001
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelinesT Nordøy, A Husebekk, I S Aaberge, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Testicular cancer treated in a minor general oncology departmentJ Norum, T Nordøy, E Wist
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 30, 1995
[Testicular cancer treated at the regional hospital in Tromsø 1985-1993]J Norum, E Wist, T Nordøy, et al.
Anticancer Research|July 1, 1995
Subclassification of Hodgkin's disease, nodular sclerosis type. Prognostic value?J Norum, E Wist, T Nordøy, et al.
Bone Marrow Transplantation|October 12, 1999
Persistent changes in the immune system 4-10 years after ABMTT Nordøy, A Kolstad, P Endresen, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2001
Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigensT Nordøy, A Kolstad, M K Tuck, et al.
Journal of Pain and Symptom Management|July 26, 2000
High level of fatigue in lymphoma patients treated with high dose therapyH Knobel, J H Loge, T Nordøy, et al.
Bone Marrow Transplantation|November 13, 2001
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelinesT Nordøy, A Husebekk, I S Aaberge, et al.
Pageof 1